TrialInternational journal of molecular sciences2018

Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative Patients.

Koji Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.